Investigation of the Ringer Perfusion Balloon Catheter (Ringer PTCA)

N/A

Waitlist Available

Led By Kathleen Kearney, MD

Research Sponsored by Vascular Solutions LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during procedure

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a special balloon that helps open blocked heart arteries in adults who need non-emergency treatment. The balloon inflates to widen the arteries, improving blood flow.

Eligible Conditions

Coronary Artery Stenosis
Coronary Stenosis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Coronary Stenosis

Rate of clinically relevant events

Secondary study objectives

Ringer Inflation

Successful PCI

TIMI Flow

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: ExperimentalExperimental Treatment1 Intervention

Adult subjects clinically indicated for non-emergent percutaneous coronary intervention (PCI) as a stand-alone procedure or following non-emergent diagnostic angiography performed during the same procedure that, in the physician's estimation, requires prolonged balloon inflation with distal perfusion.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Ringer Perfusion Balloon Catheter

2022

N/A

~60

Do I qualify?Apply below to find out